COMPARISON

Glucagon vs Triptorelin

5 attributes held for at least one of the two. 4 differ. Each value carries the register it came from and the date that register was read.

Answer

Glucagon is authorised or registered in 10 and Triptorelin in 10 of the 10 registers read. Glucagon: highest phase Phase 4 (after approval). Triptorelin: highest phase Phase 4 (after approval). 0 registered trials include both.

States no view on which is preferable, safer or more effective. Not medical advice.

GlucagonTriptorelin
Registered trials
differs
1514
clinicaltrials.gov · 2026-10-03
317
clinicaltrials.gov · 2026-10-03
FDA label
differs
FDA-approved: Glucagon
openfda · 2026-10-03T17:23:44.062Z
FDA-approved: Trelstar
openfda · 2026-10-03T17:23:44.062Z
EU authorisation
Authorised
ema · 2026-10-03
Authorised
ema · 2026-08-31
EU authorised on
differs
2019-12-16
ema · 2026-10-03
Not checked
no record of "authorisedOn" for triptorelin
ATC code
differs
H04AA01
ema · 2026-10-03
Not checked
no record of "atcCode" for triptorelin

LEGAL STATUS

Approval in each country read

CountryGlucagonTriptorelinRegister
United StatesFDA-approvedFDA-approvedRegulator FDA
European UnionAuthorisedAuthorisedRegulator EMA
United KingdomAuthorisedAuthorisedRegulator MHRA
CanadaAuthorisedAuthorisedRegulator Health Canada
AustraliaRegisteredRegisteredRegulator TGA
SwitzerlandAuthorisedAuthorisedRegulator Swissmedic
BrazilRegistadoRegistadoRegulator ANVISA
SerbiaAuthorisedAuthorisedRegulator ALIMS
SingaporeRegisteredRegisteredRegulator HSA
TurkeyRuhsatliRuhsatliRegulator TITCK

Values reproduce public registers on the dates shown. This comparison states no view on which compound is preferable, safer or more effective. Not medical, legal or regulatory advice.

WEEKLY

Register Watch, weekly

New trials, approvals and enforcement actions. One email a week.